{"id":251416,"date":"2024-07-31T00:00:00","date_gmt":"2024-07-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidop0029-biopharma-retinal-vein-occlusion-epidemiology\/"},"modified":"2026-03-31T10:29:04","modified_gmt":"2026-03-31T10:29:04","slug":"epidop0029-biopharma-retinal-vein-occlusion-epidemiology-extrapolated-worldwide-coverage","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidop0029-biopharma-retinal-vein-occlusion-epidemiology-extrapolated-worldwide-coverage\/","title":{"rendered":"Retinal Vein Occlusion &#8211; Epidemiology &#8211; Extrapolated Worldwide Coverage"},"content":{"rendered":"<p><u>Clarivate<\/u>\u2019s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key retinal vein occlusion\u00a0patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download.<\/p>\n<p>Use the Extrapolated Worldwide Coverage dashboard to do the following:<\/p>\n<ul>\n<li>View 10-year forecasts of the first-line drug-treatable population and diagnosed incident cases for all 171 countries, stratified by region and World Bank income status.<\/li>\n<li>Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.<\/li>\n<li>Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as <abbr title=\"gross domestic product\">GDP<\/abbr> per capita and healthcare spend per capita.<\/li>\n<li>Generate and export global heat maps of disease risk or patient population size.<\/li>\n<\/ul>\n<p>The Extrapolated Worldwide Coverage dashboard is available as an Excel file in the \u201cDownloads\u201d section. It is available for purchase by clients who subscribe to all 45 countries covered by <u>Clarivate<\/u>\u00a0Epidemiology. For subscription and entitlement queries, please contact <a href=\"mailto:DRG.support@clarivate.com?subject=Epidemiology%20dashboard%20query\">DRG.support@clarivate.com<\/a>.<\/p>\n","protected":false},"template":"","class_list":["post-251416","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-ophthalmology","biopharma-therapy-areas-retinal-vein-occlusion","biopharma-product-epidemiology","biopharma-geography-us","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251416\/revisions"}],"predecessor-version":[{"id":283852,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251416\/revisions\/283852"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}